Erscheint 6 Ausgaben pro Jahr
ISSN Druckformat: 1040-8401
ISSN Online: 2162-6472
IF:
1.3
5-Year IF:
2.6
Eigenfactor:
0.00079
JCI:
0.24
SJR:
0.429
SNIP:
0.287
CiteScore™::
2.7
H-Index:
81
Indexed in
Dendritic Cell Cross Talk with Innate and Innate-like Effector Cells in Antitumor Immunity: Implications for DC Vaccination
Get access
ABSTRAKT
Dendritic cells (DCs) are key players in the induction of immune responses. Adoptive transfer of autologous mature DCs loaded with tumor-associated antigens is a promising therapy for the treatment of immunogenic tumors. For a long time, its therapeutic activity was thought to depend solely on the induction of tumor-specific CD8+ and CD4+ T cell responses. More recently, DCs were shown to bidirectionally interact with innate and innate-like immune cells, including natural killer (NK), invariant natural killer T (iNKT), and γδ T cells. These effector cells can amplify responses induced by DCs via several mechanisms, including induction of DC maturation and conventional T cell priming. In addition, NK, iNKT, and γδ T cells possess cytolytic activity and can act directly on tumor cells. Therapeutic strategies targeting these innate and innate-like immune cells hence hold potential to improve current DC vaccination protocols.
-
Sköld Annette E., van Beek Jasper J. P., Sittig Simone P., Bakdash Ghaith, Tel Jurjen, Schreibelt Gerty, de Vries I. Jolanda M., Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets, Cancer Immunology, Immunotherapy, 64, 11, 2015. Crossref
-
van Beek Jasper J. P., Gorris Mark A. J., Sköld Annette E., Hatipoglu Ibrahim, Van Acker Heleen H., Smits Evelien L., de Vries I. Jolanda M., Bakdash Ghaith, Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity, OncoImmunology, 5, 10, 2016. Crossref
-
Koido Shigeo, Dendritic-Tumor Fusion Cell-Based Cancer Vaccines, International Journal of Molecular Sciences, 17, 6, 2016. Crossref
-
van Beek Jasper, Martens Anne, Bakdash Ghaith, de Vries I., Innate Lymphoid Cells in Tumor Immunity, Biomedicines, 4, 1, 2016. Crossref
-
Yan Lin-Hai, Chen Zhi-Ning, Li Li, Chen Jia, Mo Xian-Wei, Qin Yu-Zhou, Wei Wen-E, Qin Hai-Quan, Lin Yuan, Chen Jian-Si, E2F-1 promotes DAPK2-induced anti-tumor immunity of gastric cancer cells by targeting miR-34a, Tumor Biology, 37, 12, 2016. Crossref
-
Land W. G., Agostinis P., Gasser S., Garg A. D., Linkermann A., DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing, American Journal of Transplantation, 16, 12, 2016. Crossref
-
Oth Tammy, Vanderlocht Joris, Van Elssen Catharina H. M. J., Bos Gerard M. J., Germeraad Wilfred T. V., Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination, Mediators of Inflammation, 2016, 2016. Crossref
-
Penafuerte Claudia, Perez-Quintero Luis Alberto, Vinette Valerie, Hatzihristidis Teri, Tremblay Michel L., Mining the Complex Family of Protein Tyrosine Phosphatases for Checkpoint Regulators in Immunity, in Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity, 410, 2017. Crossref
-
Anguille Sébastien, Van Acker Heleen H., Van den Bergh Johan, Willemen Yannick, Goossens Herman, Van Tendeloo Viggo F., Smits Evelien L., Berneman Zwi N., Lion Eva, Lapteva Natalia, Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner, PLOS ONE, 10, 5, 2015. Crossref
-
Lopez-Lastra Silvia, Masse-Ranson Guillemette, Fiquet Oriane, Darche Sylvie, Serafini Nicolas, Li Yan, Dusséaux Mathilde, Strick-Marchand Helene, Di Santo James P., A functional DC cross talk promotes human ILC homeostasis in humanized mice, Blood Advances, 1, 10, 2017. Crossref
-
Kajihara Mikio, Takakura Kazuki, Kanai Tomoya, Ito Zensho, Saito Keisuke, Takami Shinichiro, Shimodaira Shigetaka, Okamoto Masato, Ohkusa Toshifumi, Koido Shigeo, Dendritic cell-based cancer immunotherapy for colorectal cancer, World Journal of Gastroenterology, 22, 17, 2016. Crossref
-
Land Walter Gottlieb, Activation and Function of Innate Lymphoid Cells, in Damage-Associated Molecular Patterns in Human Diseases, 2018. Crossref
-
Versteven Maarten, Van den Bergh Johan M. J., Marcq Elly, Smits Evelien L. J., Van Tendeloo Viggo F. I., Hobo Willemijn, Lion Eva, Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer, Frontiers in Immunology, 9, 2018. Crossref
-
Castella Barbara, Melaccio Assunta, Foglietta Myriam, Riganti Chiara, Massaia Massimo, Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma, Frontiers in Oncology, 8, 2018. Crossref
-
Sarhan Maysa, Land Walter G., Tonnus Wulf, Hugo Christian P., Linkermann Andreas, Origin and Consequences of Necroinflammation, Physiological Reviews, 98, 2, 2018. Crossref
-
Guazzo Riccardo, Gardin Chiara, Bellin Gloria, Sbricoli Luca, Ferroni Letizia, Ludovichetti Francesco, Piattelli Adriano, Antoniac Iulian, Bressan Eriberto, Zavan Barbara, Graphene-Based Nanomaterials for Tissue Engineering in the Dental Field, Nanomaterials, 8, 5, 2018. Crossref
-
Sköld Annette E., Mathan Till S. M., van Beek Jasper J. P., Flórez-Grau Georgina, van den Beukel Michelle D., Sittig Simone P., Wimmers Florian, Bakdash Ghaith, Schreibelt Gerty, de Vries I. Jolanda M., Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells, Cancer Immunology, Immunotherapy, 67, 9, 2018. Crossref
-
Warner Kathrin, Ohashi Pamela S., ILC regulation of T cell responses in inflammatory diseases and cancer, Seminars in Immunology, 41, 2019. Crossref
-
Yin Ying, Yu Weili, Li Yujie, Liu Kun, Zai Xiaodong, Zhang Jun, Fu Ling, Hu Tao, Xu Junjie, Chen Wei, Self-conjugated protective antigen elicits strong and durable protective antibody response against anthrax, International Journal of Biological Macromolecules, 137, 2019. Crossref
-
Lelaidier Martin, Dìaz-Rodriguez Yildian, Cordeau Martine, Cordeiro Paulo, Haddad Elie, Herblot Sabine, Duval Michel, TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells, Oncotarget, 6, 30, 2015. Crossref
-
Van Acker Heleen H., Beretta Ottavio, Anguille Sébastien, Caluwé Lien De, Papagna Angela, Van den Bergh Johan M., Willemen Yannick, Goossens Herman, Berneman Zwi N., Van Tendeloo Viggo F., Smits Evelien L., Foti Maria, Lion Eva, Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells, Oncotarget, 8, 8, 2017. Crossref
-
van Beek Jasper J.P., Flórez-Grau Georgina, Gorris Mark A.J., Mathan Till S.M., Schreibelt Gerty, Bol Kalijn F., Textor Johannes, de Vries I. Jolanda M., Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination, Cell Reports, 30, 4, 2020. Crossref
-
Mattei Fabrizio, Andreone Sara, Marone Giancarlo, Gambardella Adriana Rosa, Loffredo Stefania, Varricchi Gilda, Schiavoni Giovanna, Eosinophils in the Tumor Microenvironment, in Tumor Microenvironment, 1273, 2020. Crossref
-
Galati Domenico, Zanotta Serena, Bocchino Marialuisa, De Filippi Rosaria, Pinto Antonio, The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?, Cancer Immunology, Immunotherapy, 70, 7, 2021. Crossref
-
Dillman Robert O, Nistor Gabriel I, Cornforth Andrew N, Dendritic cell vaccines for melanoma: past, present and future, Melanoma Management, 3, 4, 2016. Crossref
-
Rajendrakumar Santhosh Kalash, Uthaman Saji, Cho Chong-Su, Park In-Kyu, Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment, Biomacromolecules, 19, 6, 2018. Crossref
-
Peil Jennifer, Bock Felix, Kiefer Friedemann, Schmidt Rebecca, Heindl Ludwig M., Cursiefen Claus, Schlereth Simona L., New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells, International Journal of Molecular Sciences, 23, 3, 2022. Crossref
-
Lee Derek, Rosenthal Carl J., Penn Natalie E., Dunn Zachary Spencer, Zhou Yang, Yang Lili, Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy, Cancers, 14, 12, 2022. Crossref
-
Wu Long, Zhang Huan, Jiang Yixing, Gallo Robert C., Cheng Hua, Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells, Proceedings of the National Academy of Sciences, 115, 19, 2018. Crossref
-
Liu Kaiyuan, Liao Yuxin, Zhou Zifei, Zhang Li, Jiang Yingying, Lu Hengli, Xu Tianyang, Yang Dong, Gao Qiuming, Li Zihua, Tan Shuo, Cao Wentao, Chen Feng, Li Guodong, Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunity, Biomaterials, 282, 2022. Crossref
-
Chan Kok Fei, Duarte Jessica Da Gama, Ostrouska Simone, Behren Andreas, γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells, Frontiers in Immunology, 13, 2022. Crossref
-
Zhao Liwei, Zhang Shuai, Kepp Oliver, Kroemer Guido, Liu Peng, Dendritic cell transfer for cancer immunotherapy, in Adoptive Cell Transfer, 370, 2022. Crossref